Neoleukin Therapeutics Inc (NLTX)

Sector:
HEALTH CARE
Industry:
PHARMACEUTICALS
SIC:
PHARMACEUTICAL PREPARATIONS
CEO:
Jonathan G. Drachman
Employees:
90
SUITE 360 - 1616 EASTLAKE AVE EAST SEATTLE WA 98102
206-732-2133

Neoleukin Therapeutics, Inc. develops immunotherapies for cancer, inflammation, and autoimmunity disorders using protein design technology. The company's lead product candidate is NL-201, a de novo protein designed to mimic the therapeutic activity of the cytokines interleukin (IL)-2/IL-15 for the treatment of various types of cancer, including renal cell carcinoma and melanoma.

Data derived from most recent annual or quarterly report
Market Cap 29.466 Million Shares Outstanding42.828 Million Avg 30-day Volume 134.172 Thousand
P/E Ratio0.0 Dividend Yield0.0 EPS-0.28
Price to Revenue0.0 Debt to Equity0.0 EBITDA-59.273 Million
Price to Book Value0.0 Operating Margin0.0 Enterprise Value0
Current Ratio0 EPS Growth-0.4 Quick Ratio0
1 Yr BETA 0.5249 52-week High/Low 0.94 / 0.38 Profit Margin0.0
Operating Cash Flow Growth-28.7255 Free Cash Flow to Firm (FCFF) TTM -40.467 Million Free Cash Flow to Equity (FCFE) TTM-44.97 Million
Altman Z-Score0.0
Earnings Report2023-11-13

Are you looking for this stock instead?

View SEC Filings from NLTX instead.

View recent insider trading info

Neoleukin Therapeutics Inc YCharts
Yahoo! Finance finviz
SEC Web Site SEC DEF 14A Filings

Funds Holding NLTX (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
Click for Additional Filters
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding NLTX

Download CSV

Active Schedule 13D and 13G filings

Please sign in first

Recent Filings

Financial Reporting

Ownership

  • 4: filed on 2023-08-14 by SMITH SEAN MICHAEL
  • 4: filed on 2023-06-09 by SIMPSON TODD E
  • 4: filed on 2023-06-09 by PALEKAR ROHAN
  • 4: filed on 2023-06-09 by NOONBERG SARAH B.
  • 4: filed on 2023-06-09 by LAVELLE ERIN
  • 4: filed on 2023-06-09 by BABLER MARTIN
  • 4: filed on 2023-04-04 by PATEL PRITI
  • 4: filed on 2023-02-03 by SMITH SEAN MICHAEL
  • 4: filed on 2023-02-03 by PATEL PRITI
  • 4: filed on 2022-08-12 by SMITH SEAN MICHAEL

    • Events (8k)

  • 8-K: filed on 2023-09-22:
    Item 3.03: Material Modifications to Rights of Security Holders
    Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
    Item 8.01: Other Events
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2023-07-18:
    Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
    Item 1.01: Entry into a Material Definitive Agreement
    Item 3.02: Unregistered Sales of Equity Securities
    Item 5.01: Changes in Control of Registrant
    Item 7.01: Regulation FD Disclosure
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2023-06-12:
    Item 5.07: Submission of Matters to a Vote of Security Holders
  • 8-K: filed on 2023-04-03:
    Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
  • 8-K: filed on 2023-03-10:
    Item 2.05: Cost Associated with Exit or Disposal Activities
    Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
  • 8-K: filed on 2023-03-08:
    Item 7.01: Regulation FD Disclosure
    Item 9.01: Financial Statements and Exhibits
  • 8-K/A: filed on 2023-01-23:
    Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2022-11-30:
    Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2022-11-14:
    Item 2.02: Results of Operations and Financial Condition
    Item 7.01: Regulation FD Disclosure
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2022-10-31:
    Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing

    • Proposed Sales (Form 144)

    Proxy

    Prospectus

    All

    Open Market Buys/Sells Last 60 Days

    Open Market Buys (P)

    2.3 Million total shares from 12 transactions

    Open Market Sells (S)

    1.3 Thousand total shares from 1 transactions

    Exercise Derivative Conversion (M)

    5 Thousand total shares from 1 transactions

    Current/Former Insiders

    Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

    BAKER BROS. ADVISORS LP

    667, L.P.

    BAKER BROTHERS LIFE SCIENCES LP

    BAKER FELIX

    BAKER JULIAN

    BAKER BROS. ADVISORS (GP) LLC

    • Director
    • 10% Owner
    		 35,442,109 2023-08-15 2

    SMITH SEAN MICHAEL INTERIM CFO, PRIN ACCT OFF

    • Officer
    		 21,637 2023-08-10 2

    SIMPSON TODD E

    • Director
    		 0 2023-06-08 1

    PALEKAR ROHAN

    • Director
    		 0 2023-06-08 1

    BABLER MARTIN

    • Director
    		 0 2023-06-08 1

    NOONBERG SARAH B.

    • Director
    		 0 2023-06-08 1

    LAVELLE ERIN

    • Director
    		 0 2023-06-08 1

    PATEL PRITI

    • FORMER CHIEF MEDICAL OFFICER
    		 37,313 2023-03-31 2

    DRACHMAN JONATHAN G PRESIDENT AND CEO

    • Officer
    • Director
    		 350,000 2022-08-02 0

    WALKEY CARL SENIOR VICE PRESIDENT

    • Officer
    		 150,000 2022-08-02 0

    COCHENER DONNA GENERAL COUNSEL, SVP LEGAL

    • Officer
    		 100,000 2022-08-02 0

    HO ROBERT CHIEF FINANCIAL OFFICER

    • Officer
    		 70,000 2022-02-01 0

    VANCE HOLLY GENERAL COUNSEL

    • Officer
    		 100,000 2021-08-03 0

    WILLIAMS LEWIS T

    • Director
    		 25,000 2021-05-11 0

    LAVELLE ERIN M.

    • Director
    		 25,000 2021-05-11 0

    NOLAN SEAN P.

    • Director
    		 0 2020-05-05 0

    REDMILE GROUP, LLC

    GREEN JEREMY

    • 10% Owner
    		 4,041,211 2020-03-27 0

    BOYD META CANTEY

    • Director
    		 0 2019-08-08 0

    MAIN DAVID PRESIDENT AND CEO

    • Officer
    • Director
    		 0 2018-08-07 0

    ALAM KAMRAN CFO, VICE PRESIDENT FINANCE

    • Officer
    		 0 2018-08-07 0

    MACKENZIE LLOYD CHIEF OPERATING OFFICER

    • Officer
    		 0 2018-08-07 0

    MCCLOSKEY SHELLEY VP, HR AND ADMINISTRATION

    • Officer
    		 0 2018-08-07 0

    LEVITT DANIEL J

    • Director
    		 0 2018-05-14 0

    PELZER ROBERT

    • Director
    		 0 2018-05-07 0

    BRIDGER GARY

    • Director
    		 0 2018-05-07 0

    TROUPIN BARBARA CHIEF MEDICAL OFFICER

    • Officer
    		 0 2018-03-09 0

    JENKINS ABIGAIL CHIEF COMMERCIAL OFFICER

    • Officer
    		 0 2018-03-09 0

    LEVY RICHARD S

    • Director
    		 0 2017-03-23 0

    NEU KELVIN

    • Director
    		 36 2017-03-23 0

    MITCHELL DAVID CHILTON VP GLOBAL REGULATORY & QUALITY

    • Officer
    		 0 2017-03-08 0

    BAKER BROS. ADVISORS LP

    BAKER BROS. ADVISORS (GP) LLC

    BAKER FELIX

    BAKER JULIAN

    • 10% Owner
    		 10,936,414 2017-01-09 0

    SHREWSBURY STEPHEN B CMO; SENIOR VP CLINICAL DEV.

    • Officer
    		 0 2016-03-10 0

    PFIZER INC

    • 10% Owner
    		 No longer subject to file 2015-08-10 0

    JOHNSON & JOHNSON

    JOHNSON & JOHNSON INNOVATION - JJDC, INC.

    • 10% Owner
    		 No longer subject to file 2015-08-10 0

    BREWER RICHARD B EXECUTIVE CHAIRMAN

    • Officer
    • Director
    		 1,568,750 2012-03-30 0

    KAZAM JOSHUA A PRESIDENT & CEO

    • Officer
    • Director
    		 3,036,157 2012-03-30 0

    EVANS DARON CHIEF FINANCIAL OFFICER

    • Officer
    		 1,092,735 2012-03-30 0

    LIEU HSIAO EXECUTIVE VP, CLINICAL DEV.

    • Officer
    		 528,143 2012-03-30 0

    KASH PETER M

    • Director
    		 2,453,193 2009-07-07 0

    TANEN DAVID M

    • Director
    		 1,658,646 2008-12-16 0

    STRUMPH PETER M CHIEF EXECUTIVE OFFICER

    • Officer
    • Director
    		 7,780 2008-12-12 0

    Insider Transactions Last 60 Days

    Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
    Disposed    		 Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days

    BAKER BROS. ADVISORS LP - Director - > 10% Owner see footnotes

    667, L.P. - Director - > 10% Owner see footnotes

    BAKER BROTHERS LIFE SCIENCES LP - Director - > 10% Owner see footnotes

    BAKER FELIX - Director - > 10% Owner see footnotes

    BAKER JULIAN - Director - > 10% Owner see footnotes

    BAKER BROS. ADVISORS (GP) LLC - Director - > 10% Owner see footnotes

    		2023-08-17 17:08:02 -0400 2023-08-17 P 5,041 $0.69 a 494,133 indirect -1.3333 -4.1333 0.0 1 -4.1333 6

    BAKER BROS. ADVISORS LP - Director - > 10% Owner see footnotes

    667, L.P. - Director - > 10% Owner see footnotes

    BAKER BROTHERS LIFE SCIENCES LP - Director - > 10% Owner see footnotes

    BAKER FELIX - Director - > 10% Owner see footnotes

    BAKER JULIAN - Director - > 10% Owner see footnotes

    BAKER BROS. ADVISORS (GP) LLC - Director - > 10% Owner see footnotes

    		2023-08-17 17:08:02 -0400 2023-08-17 P 7,676 $0.69 a 489,092 indirect -1.3333 -4.1333 0.0 1 -4.1333 6

    BAKER BROS. ADVISORS LP - Director - > 10% Owner see footnotes

    667, L.P. - Director - > 10% Owner see footnotes

    BAKER BROTHERS LIFE SCIENCES LP - Director - > 10% Owner see footnotes

    BAKER FELIX - Director - > 10% Owner see footnotes

    BAKER JULIAN - Director - > 10% Owner see footnotes

    BAKER BROS. ADVISORS (GP) LLC - Director - > 10% Owner see footnotes

    		2023-08-17 17:08:02 -0400 2023-08-17 P 61,134 $0.69 a 5,612,949 indirect -1.3333 -4.1333 0.0 1 -4.1333 6

    BAKER BROS. ADVISORS LP - Director - > 10% Owner see footnotes

    667, L.P. - Director - > 10% Owner see footnotes

    BAKER BROTHERS LIFE SCIENCES LP - Director - > 10% Owner see footnotes

    BAKER FELIX - Director - > 10% Owner see footnotes

    BAKER JULIAN - Director - > 10% Owner see footnotes

    BAKER BROS. ADVISORS (GP) LLC - Director - > 10% Owner see footnotes

    		2023-08-17 17:08:02 -0400 2023-08-17 P 93,091 $0.69 a 5,551,815 indirect -1.3333 -4.1333 0.0 1 -4.1333 6

    BAKER BROS. ADVISORS LP - Director - > 10% Owner see footnotes

    667, L.P. - Director - > 10% Owner see footnotes

    BAKER BROTHERS LIFE SCIENCES LP - Director - > 10% Owner see footnotes

    BAKER FELIX - Director - > 10% Owner see footnotes

    BAKER JULIAN - Director - > 10% Owner see footnotes

    BAKER BROS. ADVISORS (GP) LLC - Director - > 10% Owner see footnotes

    		2023-08-17 17:08:02 -0400 2023-08-16 P 366 $0.68 a 481,416 indirect -1.3333 -4.1333 0.0 1 -4.1333 6

    BAKER BROS. ADVISORS LP - Director - > 10% Owner see footnotes

    667, L.P. - Director - > 10% Owner see footnotes

    BAKER BROTHERS LIFE SCIENCES LP - Director - > 10% Owner see footnotes

    BAKER FELIX - Director - > 10% Owner see footnotes

    BAKER JULIAN - Director - > 10% Owner see footnotes

    BAKER BROS. ADVISORS (GP) LLC - Director - > 10% Owner see footnotes

    		2023-08-17 17:08:02 -0400 2023-08-16 P 4,434 $0.68 a 5,458,724 indirect -1.3333 -4.1333 0.0 1 -4.1333 6

    BAKER BROS. ADVISORS LP - Director - > 10% Owner see footnotes

    667, L.P. - Director - > 10% Owner see footnotes

    BAKER BROTHERS LIFE SCIENCES LP - Director - > 10% Owner see footnotes

    BAKER FELIX - Director - > 10% Owner see footnotes

    BAKER JULIAN - Director - > 10% Owner see footnotes

    BAKER BROS. ADVISORS (GP) LLC - Director - > 10% Owner see footnotes

    		2023-08-17 17:08:02 -0400 2023-08-16 P 17,124 $0.68 a 481,050 indirect -1.3333 -4.1333 0.0 1 -4.1333 6

    BAKER BROS. ADVISORS LP - Director - > 10% Owner see footnotes

    667, L.P. - Director - > 10% Owner see footnotes

    BAKER BROTHERS LIFE SCIENCES LP - Director - > 10% Owner see footnotes

    BAKER FELIX - Director - > 10% Owner see footnotes

    BAKER JULIAN - Director - > 10% Owner see footnotes

    BAKER BROS. ADVISORS (GP) LLC - Director - > 10% Owner see footnotes

    		2023-08-17 17:08:02 -0400 2023-08-16 P 207,676 $0.68 a 5,454,290 indirect -1.3333 -4.1333 0.0 1 -4.1333 6

    BAKER BROS. ADVISORS LP - Director - > 10% Owner see footnotes

    667, L.P. - Director - > 10% Owner see footnotes

    BAKER BROTHERS LIFE SCIENCES LP - Director - > 10% Owner see footnotes

    BAKER FELIX - Director - > 10% Owner see footnotes

    BAKER JULIAN - Director - > 10% Owner see footnotes

    BAKER BROS. ADVISORS (GP) LLC - Director - > 10% Owner see footnotes

    		2023-08-17 17:08:02 -0400 2023-08-15 P 358 $0.67 a 463,926 indirect -1.3333 -4.1333 0.0 1 -4.1333 6

    BAKER BROS. ADVISORS LP - Director - > 10% Owner see footnotes

    667, L.P. - Director - > 10% Owner see footnotes

    BAKER BROTHERS LIFE SCIENCES LP - Director - > 10% Owner see footnotes

    BAKER FELIX - Director - > 10% Owner see footnotes

    BAKER JULIAN - Director - > 10% Owner see footnotes

    BAKER BROS. ADVISORS (GP) LLC - Director - > 10% Owner see footnotes

    		2023-08-17 17:08:02 -0400 2023-08-15 P 4,342 $0.67 a 5,246,614 indirect -1.3333 -4.1333 0.0 1 -4.1333 6

    BAKER BROS. ADVISORS LP - Director - > 10% Owner see footnotes

    667, L.P. - Director - > 10% Owner see footnotes

    BAKER BROTHERS LIFE SCIENCES LP - Director - > 10% Owner see footnotes

    BAKER FELIX - Director - > 10% Owner see footnotes

    BAKER JULIAN - Director - > 10% Owner see footnotes

    BAKER BROS. ADVISORS (GP) LLC - Director - > 10% Owner see footnotes

    		2023-08-17 17:08:02 -0400 2023-08-15 P 143,519 $0.63 a 463,568 indirect -1.3333 -4.1333 0.0 1 -4.1333 6

    BAKER BROS. ADVISORS LP - Director - > 10% Owner see footnotes

    667, L.P. - Director - > 10% Owner see footnotes

    BAKER BROTHERS LIFE SCIENCES LP - Director - > 10% Owner see footnotes

    BAKER FELIX - Director - > 10% Owner see footnotes

    BAKER JULIAN - Director - > 10% Owner see footnotes

    BAKER BROS. ADVISORS (GP) LLC - Director - > 10% Owner see footnotes

    		2023-08-17 17:08:02 -0400 2023-08-15 P 1,740,581 $0.63 a 5,242,272 indirect -1.3333 -4.1333 0.0 1 -4.1333 6

    SMITH SEAN MICHAEL - Officer INTERIM CFO, PRIN ACCT OFF

    		2023-08-14 16:06:55 -0400 2023-08-11 S 1,323 $0.62 d 21,637 direct 4.3284 11.6418 11.9403 4 0.0 1

    SMITH SEAN MICHAEL - Officer INTERIM CFO, PRIN ACCT OFF

    		2023-08-14 16:06:55 -0400 2023-08-10 M 5,000 a 22,960 direct 4.3284 11.6418 11.9403 4 0.0 1

    SMITH SEAN MICHAEL - Officer INTERIM CFO, PRIN ACCT OFF

    		2023-08-14 16:06:55 -0400 2023-08-10 M 5,000 d 0 direct

    * -

    Transaction Code Definitions
    Code Definition
    A Grant, award or other acquisition pursuant to Rule 16b-3(d)
    C Conversion of derivative security
    D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
    E Expiration of short derivative position
    F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
    G Bona fide gift
    H Expiration (or cancellation) of long derivative position with value received
    I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
    J Other acquisition or disposition
    L Small acquisition under Rule 16a-6
    M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
    O Exercise of out-of-the-money derivative security
    P Open market or private purchase of non-derivative or derivative security
    S Open market or private sale of non-derivative or derivative security
    U Disposition pursuant to a tender of shares in a change of control transaction
    W Acquisition or disposition by will or the laws of descent and distribution
    X Exercise of in-the-money or at-the-money derivative security
    Z Deposit into or withdrawal from voting trust

    IBR Securities Loan Availability

    Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

    Security Date/Time Rebate Rate Fee Rate Shares Available
    NEOLEUKIN THERAPEUTICS INC NLTX 2023-09-22 22:15:03 UTC -2.377 7.697 1000000
    NEOLEUKIN THERAPEUTICS INC NLTX 2023-09-22 21:45:04 UTC -2.377 7.697 1000000
    NEOLEUKIN THERAPEUTICS INC NLTX 2023-09-22 21:15:04 UTC -2.377 7.697 1000000
    NEOLEUKIN THERAPEUTICS INC NLTX 2023-09-22 20:45:04 UTC -2.377 7.697 1000000
    NEOLEUKIN THERAPEUTICS INC NLTX 2023-09-22 20:15:04 UTC -2.377 7.697 1000000
    NEOLEUKIN THERAPEUTICS INC NLTX 2023-09-22 19:45:03 UTC -2.377 7.697 1000000
    NEOLEUKIN THERAPEUTICS INC NLTX 2023-09-22 19:15:04 UTC -2.377 7.697 1000000
    NEOLEUKIN THERAPEUTICS INC NLTX 2023-09-22 18:45:03 UTC -2.377 7.697 1000000
    NEOLEUKIN THERAPEUTICS INC NLTX 2023-09-22 18:15:04 UTC -2.377 7.697 1000000
    NEOLEUKIN THERAPEUTICS INC NLTX 2023-09-22 17:45:04 UTC 0.0 0.0 1000000
    NEOLEUKIN THERAPEUTICS INC NLTX 2023-09-22 17:15:04 UTC 0.0 0.0 1000000
    NEOLEUKIN THERAPEUTICS INC NLTX 2023-09-22 16:45:03 UTC -2.377 7.697 1000000
    NEOLEUKIN THERAPEUTICS INC NLTX 2023-09-22 16:15:04 UTC -2.377 7.697 1000000
    NEOLEUKIN THERAPEUTICS INC NLTX 2023-09-22 15:45:04 UTC -2.377 7.697 1000000
    NEOLEUKIN THERAPEUTICS INC NLTX 2023-09-22 15:15:04 UTC -2.377 7.697 1000000
    NEOLEUKIN THERAPEUTICS INC NLTX 2023-09-22 14:45:03 UTC -2.377 7.697 1000000
    NEOLEUKIN THERAPEUTICS INC NLTX 2023-09-22 14:15:04 UTC -2.377 7.697 1000000
    NEOLEUKIN THERAPEUTICS INC NLTX 2023-09-22 13:45:03 UTC 1.8929 3.4271 1000000
    NEOLEUKIN THERAPEUTICS INC NLTX 2023-09-22 13:15:04 UTC 1.8929 3.4271 1000000
    NEOLEUKIN THERAPEUTICS INC NLTX 2023-09-22 12:45:04 UTC 1.8929 3.4271 1000000

    Current Active Short Positions

    Holder Issuer Net Short Position Position Date Origin

    No recent transactions

    *** To see all congressional transactions (since 2022) for this stock, please use the congressional transaction search page***

    WhaleWisdom Logo

    Elevate your investments